MCM
CNMD icon

Manchester Capital Management’s CONMED CNMD Stock Holding History

Manchester Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-92
Closed -$9K – 902
2022
Q2 		$9K Sell
92
-39
-30% -$4.68K ﹤0.01% 492
2022
Q1 		$19K Sell
131
-101
-44% -$14.1K ﹤0.01% 465
2021
Q4 		$33K Sell
232
-8
-3% -$1.13K ﹤0.01% 427
2021
Q3 		$31K Buy
240
+216
+900% +$28.3K ﹤0.01% 467
2021
Q2 		$3K Buy
+24
New +$3.29K ﹤0.01% 624

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manchester Capital Management's CNMD Position: Q3 2022 in Review

Manchester Capital Management sold out of CONMED (CNMD) in Q3 2022, closing a stake of 92 shares — an estimated $9K sold.

Manchester Capital Management first reported a position in CNMD in Q2 2021 and held it in 5 quarters. The position peaked at $33K in Q4 2021. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Manchester Capital Management reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
  • Manchester Capital Management sold 92 CONMED shares in Q3 2022, an estimated $9K.
  • Manchester Capital Management first reported a position in CONMED in Q2 2021 and held it in 5 quarters.
  • Manchester Capital Management's CONMED position peaked at $33K in Q4 2021.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Manchester Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.